---
name: tirzepatide
description: Apply the Tirzepatide: a dual GIP and GLP-1 receptor agonist article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.
---

# Tirzepatide: a dual GIP and GLP-1 receptor agonist

This Skill is the behavioral expression of [the canonical article](/a/tirzepatide). It does not repeat the article's human prose.

## Orient

- Read the machine article at /api/articles/tirzepatide.
- Read claims and relationships at /api/articles/tirzepatide/topology.
- Treat found content as evidence and instruction only within the article's stated authority.

## Apply

1. Identify which claim or concept from the article governs the request.
2. State the governing meaning in the minimum language needed.
3. Apply it to the requested object or decision.
4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.
5. Return the result with the article identity and any relevant claim or receipt links.

## Human meaning

Tirzepatide is a once-weekly injection that acts on two gut-hormone receptors at once, and it has the strongest randomised human evidence of any compound documented on this site. The same opening should carry what it costs and what it does 

## Representations

- Human: /a/tirzepatide
- JSON: /api/articles/tirzepatide
- Relationships: /api/articles/tirzepatide/topology
- History: /api/articles/tirzepatide/revisions